Your shopping cart is currently empty

NLRP3/AIM2-IN-3 is a unique molecule that inhibits NLRP3 and AIM2 inflammasome activation in a species-specific manner. It has an IC50 value for cell lysis of 0.077 ± 0.008 μ M. NLRP3/AIM2-IN-3 is a potent inhibitor of NLRP3 and AIM2 inflammasome-dependent cell lysis with an IC50 value for cell lysis of 0.077 ± 0.008 μ M. NLRP3/AIM2-IN-3 inhibits LPS/nigericin NLRP3/AIM2-IN-3 inhibits LPS/nigericin-stimulated cell lysis in THP-1 macrophages with an IC50 value of 0.077 ± 0.008 μM. NLRP3/AIM2-IN-3 interferes with the interaction of NLRP3 or AIM2 with the bridging protein ASC, inhibiting oligomerization of ASC.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $68 | - | In Stock | |
| 10 mg | $109 | - | In Stock | |
| 25 mg | $228 | - | In Stock | |
| 50 mg | $372 | - | In Stock | |
| 100 mg | $597 | - | In Stock | |
| 500 mg | $1,260 | 6-8 weeks | 6-8 weeks | |
| 1 mL x 10 mM (in DMSO) | $75 | - | In Stock |
| Description | NLRP3/AIM2-IN-3 is a unique molecule that inhibits NLRP3 and AIM2 inflammasome activation in a species-specific manner. It has an IC50 value for cell lysis of 0.077 ± 0.008 μ M. NLRP3/AIM2-IN-3 is a potent inhibitor of NLRP3 and AIM2 inflammasome-dependent cell lysis with an IC50 value for cell lysis of 0.077 ± 0.008 μ M. NLRP3/AIM2-IN-3 inhibits LPS/nigericin NLRP3/AIM2-IN-3 inhibits LPS/nigericin-stimulated cell lysis in THP-1 macrophages with an IC50 value of 0.077 ± 0.008 μM. NLRP3/AIM2-IN-3 interferes with the interaction of NLRP3 or AIM2 with the bridging protein ASC, inhibiting oligomerization of ASC. |
| In vitro | NLRP3/AIM2-IN-3 (0-100 μM) exhibits significant inhibitory activity against NLRP3 and AIM2 in human THP-1 macrophages, without affecting NLRC4-dependent activation of caspase-1 or IL-1b release. It inhibits IL-1b secretion from THP-1 macrophages with an IC50 of 0.098 μM, which is nearly 150-fold and 500-fold more potent compared to its effects on J774A.1 (14.62 μM) and Bone Marrow-Derived Macrophages (BMDM) (48.98 μM), respectively. [1] |
| Molecular Weight | 266.29 |
| Formula | C16H14N2O2 |
| Cas No. | 1787787-60-3 |
| Smiles | Oc1cccc(NC(=O)Cc2ccc3cc[nH]c3c2)c1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 225 mg/mL (844.94 mM), Sonication is recommended. Methanol: 45 mg/mL (168.99 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (12.39 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
Methanol/DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.